structure of Moxifloxacin hydrochloride monohydrate CAS 192927 63 2 - Moxifloxacin hydrochloride monohydrate CAS 192927-63-2 Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions and Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

192927-63-2

Name

Mox­i­floxacin hydrochlo­ride mono­hy­drate

Syn­onyms

1-Cyclopropyl-6-fluor-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydro-3-chinolincarbonsäurehydrochloridhydrat [Ger­man] [ACD/IUPAC Name] 1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid hydrochlo­ride hydrate [ACD/IUPAC Name] 3-Quino­­linecar­boxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrochlo­ride, hydrate (1:1:1) [ACD/​Index Name] Acide 1-cyclopropyl-6-fluoro-8-méthoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydro-3-quinoléinecarboxylique, chlorhy­drate, hydrate [French] [ACD/IUPAC Name] 192927-63-2 [RN] 1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochlo­ride hydrate 1-cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochlo­ride hydrate Mox­i­floxacin hydrochlo­ride mono­hy­drate UNII-B8956S8609 1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid hydrochlo­ride hydrate

Mol­e­c­u­lar Structure

structure of Moxifloxacin hydrochloride monohydrate CAS 192927 63 2 - Moxifloxacin hydrochloride monohydrate CAS 192927-63-2

struc­ture of Mox­i­floxacin hydrochlo­ride mono­hy­drate CAS 192927-63-2

SMILES

COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.O.Cl

Std­InChI

InChI=1S/C21H24FN3O4.ClH.H2O/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24;;/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28);1H ;1H2/t11-,16+;;/m0../s1

Std­InChIKey

SKZ­IM­S­D­WAIZNDD-WJMO­HVQJSA-N

Mol­e­c­u­lar Formula

C21H27ClFN3O5

Mol­e­c­u­lar Weight

455.908

Prop­er­ties

Appear­ance

Light yel­low crystals,slightly hygro­scop­ic

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Mox­i­floxacin hydrochlo­ride mono­hy­drate CAS 192927-63-2

Stan­dard

Enter­prise stan­dard

Iden­ti­fi­ca­tion Methods

IR

Puri­ty

99%min

Spe­cif­ic Opti­cal Rotation

-125°~-138°

PH

3.9-4.6

Water

4.5% max

Sul­phat­ed ash

0.1% max

Total Impu­ri­ties

0.3% max

Stor­age

Under the room tem­per­a­ture and away from light

Appli­ca­tion

Used as the Phar­ma­ceu­ti­cal inter­me­di­ates

Links

This prod­uct is devel­oped by our RandD com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​m​o​x​i​f​l​o​x​a​c​i​n​-​h​y​d​r​o​c​h​l​o​r​i​d​e​-​m​o​n​o​h​y​d​r​a​t​e​-​c​a​s​-​1​9​2​9​2​7​-​6​3​-2/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone). 

























    Please prove you are human by select­ing the tree.




    andD pur­pose. It may be tox­ic or haz­ardous, and should be han­dled only by qual­i­fied indi­vid­u­als trained in lab­o­ra­to­ry pro­ce­dures. The buy­er will be respon­si­ble to warn and inform any per­son that may be in con­tact with the prod­uct of the poten­tial risks and haz­ards, as well as to ensure that pur­chase, use and dis­pos­al of the prod­uct com­ply with local laws and regulations.